$ATRC News

AtriCure: Promising Cardiovascular Surgical Platform

Two AtriCure Directors Trimmed Shares After a Strong Quarter. Here's What Matters for Investors

An AtriCure Director Sold $905,000 in Stock. Here's How to Read It

Director At AtriCure Sells $134K Of Stock

Insider Selling: Vinayak Doraiswamy Unloads $233K Of AtriCure Stock

Board Member At AtriCure Exercises Options Worth $491K

AtriCure, Inc. 2026 Q2 - Results - Earnings Call Presentation

Are Options Traders Betting on a Big Move in AtriCure Stock?

Is AtriCure (ATRC) A Bargain Following Its New Share Registration Filings?

UBS Maintains Buy on AtriCure, Lowers Price Target to $50

AtriCure, Inc. (ATRC) Beat Earnings Estimates. Here’s What Could Drive ATRC Stock Next

AtriCure to Participate at Upcoming Investor Conferences

AtriCure Inc (ATRC) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and Profitability ...

AtriCure (ATRC) Reports Q2 Earnings: What Key Metrics Have to Say

AtriCure Q2 Earnings Call Highlights

AtriCure, Inc. (ATRC) Q2 2026 Earnings Call Transcript

AtriCure (ATRC) Q2 Earnings and Revenues Top Estimates

AtriCure (NASDAQ:ATRC) Profitability Surge Drives After-Hours Rally Despite Inline Revenue

AtriCure Reports Second Quarter 2026 Financial Results

AtriCure Reports Q2 2026 Results: Full Earnings Call Transcript